gamma-aminobutyric acid has been researched along with Fabry Disease in 2 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Fabry Disease: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years." | 9.10 | Use of gabapentin to reduce chronic neuropathic pain in Fabry disease. ( Beck, M; Birklein, F; Kim, KS; Krummenauer, F; Kutschke, G; Mengel, E; Ries, M, 2003) |
| "The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years." | 5.10 | Use of gabapentin to reduce chronic neuropathic pain in Fabry disease. ( Beck, M; Birklein, F; Kim, KS; Krummenauer, F; Kutschke, G; Mengel, E; Ries, M, 2003) |
| "Neuropathic pain is one of the key features of (classical) Fabry disease (FD)." | 2.53 | Pain management strategies for neuropathic pain in Fabry disease--a systematic review. ( Biegstraaten, M; Hollak, CE; Linthorst, GE; Schuller, Y; Van Schaik, IN, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schuller, Y | 1 |
| Linthorst, GE | 1 |
| Hollak, CE | 1 |
| Van Schaik, IN | 1 |
| Biegstraaten, M | 1 |
| Ries, M | 1 |
| Mengel, E | 1 |
| Kutschke, G | 1 |
| Kim, KS | 1 |
| Birklein, F | 1 |
| Krummenauer, F | 1 |
| Beck, M | 1 |
1 review available for gamma-aminobutyric acid and Fabry Disease
| Article | Year |
|---|---|
Pain management strategies for neuropathic pain in Fabry disease--a systematic review.
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Fabry Disease; Gabapentin; gamm | 2016 |
1 trial available for gamma-aminobutyric acid and Fabry Disease
| Article | Year |
|---|---|
Use of gabapentin to reduce chronic neuropathic pain in Fabry disease.
Topics: Acetates; Adolescent; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Fabry Disease; Ga | 2003 |